AbbVie joins our list of companies with regular, stable or growing dividends. The U.S. pharmaceutical group is supported by the growth of Skyrizi and Rinvoq, and its stock trades under the ticker ABBV.
ABBVIE INC
ABBV
New York Stock Exchange
249,46 $
Last updated: 2026-08-16
AbbVie is a global biopharmaceutical company focused on discovering and delivering innovative medicines for serious health conditions.
Dividend (2025)
6,56 $
Yield (2025)
2,63 %
Market Cap
440.83B $
P/E Ratio
70,56
Dividend History
Link:
investors.abbvie.com
| Year | Dividend | Yield |
|---|---|---|
| 2025 | 6,56 $ | — |
| 2024 | 6,20 $ | — |
| 2023 | 5,92 $ | — |
| 2022 | 5,64 $ | — |
| 2021 | 5,20 $ | — |
Dividend growth rate:
5.98% (4-year CAGR)
Quick Analysis
Dividend Score
6/10
Key Insights
- Consistent dividend history
Continue after this ad
Track This Stock
Get alerts and detailed analysis
Top Dividend Stocks
FinanceM6 METROPOLE TELE
MMT
10.38%
See stock →
ITOCHU CORPORATION
8001
9.69%
See stock →
FDJ UNITED
FDJU
9.15%
See stock →
* Financial information and dividend data are provided for informational purposes only and do not constitute investment advice.